Production of Two Excedrin Painkillers Halted
Production and distribution of Excedrin Extra Strength and Excedrin Migraine products have been temporarily stopped, maker GlaxoSmithKline said Tuesday.
Pain Management
FDA Panels Vote “No” on Oxycodone Extended-Release Tablets
Safety and efficacy was based on demonstration of bioequivalence to Oxycontin.
Closed-Loop Spinal Cord Stimulation for the Management of Chronic Back and Leg Pain [Part 2]: Expert Perspective
Lead author Nagy Mekhail, MD, PhD discusses the importance of neuromodulation, specifically a closed loop spinal cord stimulation system (SCS), for the management of chronic pain.
FDA Committees Vote on Novel Opioid for Chronic Low Back Pain
As a result of the vote, Nektar has decided to withdraw the New Drug Application for oxycodegol and to cease further development of the product.
ACHIEVE II Trial Finds Ubrogepant Superior to Placebo for Pain Freedom in Moderate, Severe Migraine
Acute treatment of migraine with ubrogepant, an oral calcitonin gene-related peptide antagonist, was superior to placebo for migraine pain freedom.
Closed-Loop Spinal Cord Stimulation for the Management of Chronic Back and Leg Pain [Part 1]
Spinal cord stimulation (SCS) with a closed-loop system that uses recorded evoked compound action potentials (ECAPs) is superior to a fixed-output, open-loop system for patients with chronic back and leg pain.
Acupuncture and Acupressure May Aid in Pain Management for Patients With Cancer
Researchers found the use of acupuncture and/or acupressure is associated with reduced cancer pain and decreased use of analgesics.
FDA to Review Capsaicin Patch for Painful Diabetic Peripheral Neuropathy
The FDA has a supplemental New Drug Application for capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy.
Prescription Pain and Sleep Medications Linked to Increased Risk for Frailty Among Elderly
Prescription pain and sleep drug use is significantly associated with an increased incidence of frailty.
Comorbidity-Based Migraine Subgroups Predict Progression of Episodic to Chronic Migraine
Various migraine subgroups based on comorbidities can predict the risk for the progression of episodic migraine to chronic migraine.
Next post in Migraine and Headache
